Medical weight loss is a structured program run by licensed clinicians that may include FDA-approved medicine, nutrition counseling and regular monitoring.
Newport Beach, Irvine and the rest of the county
Orange County had 3,149,507 residents in July 2025 [6]. CDC PLACES estimates 23.9% of adults have obesity and 11.5% have diagnosed diabetes [1]. City-level figures for Newport Beach or Irvine were not part of our data, so treat these county numbers as a rough guide.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Orange County, from $300 a month.
This placement is bought by a practice and carries a sponsor label. It is not an endorsement. See sponsor a city.
Hospital-based options
Hoag Metabolism and Weight Management Center is Hoag's dedicated weight program [2]. Its page does not post a self-pay price, so ask for the cost of the first visit, follow-ups and labs, and whether it takes your insurance. UCI Health is another health system in the county; we did not confirm a specific weight program page there.
Coverage after Medi-Cal's change
Medi-Cal ended adult weight-loss GLP-1 coverage on January 1, 2026; patients under 21 and those using the drugs for other approved uses, such as diabetes, may still be covered [3]. About 18.5% of county residents are 65 or older [6]; eligible Part D enrollees can use the Medicare GLP-1 Bridge for a $50 monthly copay [7]. Employer plans vary; see Zepbound insurance and Wegovy insurance.
Self-pay prices
| Drug | Per month | Fine print | Source |
|---|---|---|---|
| Foundayo tablet | $149 to $299 | The 2.5 and 5.5 mg prices are a temporary cut that runs through Dec 31, 2026 | [8] |
| Wegovy pen | $349 | New patients pay $199 for their first two low-dose fills | [4] |
| Zepbound | $299 to $449 | The $449 higher-dose price needs a refill within 45 days | [5] |
Trial averages, briefly
Main-trial averages, which no one is promised: 11.1% weight loss at 72 weeks on Foundayo 17.2 mg [9], 14.9% at 68 weeks on semaglutide 2.4 mg [10], and 20.9% at 72 weeks on tirzepatide 15 mg [11]. Side-by-side detail: Foundayo vs Wegovy pill and Wegovy vs Zepbound.
Other California guides: Los Angeles, San Diego, Beverly Hills and San Jose. The medical weight loss hub covers the basics. Prescribers can be looked up with the Medical Board of California [13].
What the labels warn about
A boxed warning covers thyroid C-cell tumors in rodents, and the drugs are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 [12] [9]. Pain in the stomach that is severe and lasting may point to pancreatitis. Allergic reactions can happen, and so can low blood sugar for people also on insulin or sulfonylureas. The drug should be stopped when pregnancy is recognized. Call 911 for an emergency.
Questions people ask
Does Hoag have a medical weight loss program?
Yes. Hoag runs the Metabolism and Weight Management Center in Orange County; its page does not list a self-pay price [2].
How many Orange County adults have obesity or diabetes?
CDC PLACES estimates 23.9% of adults in Orange County have obesity and 11.5% have diagnosed diabetes [1].
Can Orange County Medi-Cal members still get GLP-1s for weight loss?
Not adults, since Jan 1, 2026. Members under 21 keep coverage, and other medically necessary uses may still be paid for [3].
Which brand GLP-1 costs least for an Orange County cash buyer?
Can Orange County seniors use the Medicare GLP-1 Bridge?
How much weight did people lose on Foundayo in its trial?
Adults without diabetes on 17.2 mg lost an average of 11.1% of body weight at 72 weeks, versus 2.1% on placebo, in the label's main trial [9].
Sources
13 cited
- PLACES county data, 2025 release: Orange County, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- Metabolism and Weight Management Center. Hoag, Oct 17, 2026.
- California Medicaid ends coverage of GLP-1 weight loss drugs. KFF Health News, Jan 9, 2026.
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- QuickFacts: Orange County, California. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), Oct 17, 2026.
- Foundayo self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Foundayo prescribing information. Eli Lilly and Company, Jul 2026.
- Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine (PubMed), 2021.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), 2022.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Medical Board of California. Medical Board of California, accessed 2026-10-17.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.